Our work showed the significant potential of TP73 gene as a molecular characteristic for evaluating the malignancy and survival outcome of WHO grade II/III glioma, which also provided a basis for later research on TP73 gene as a molecular target for glioma targeted therapy. Here, TP73 is linked to central nervous system cancer.